BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 23322389)

  • 1. Cost-effectiveness analysis of rubella screening strategies using electronic medical records.
    Straub HL; Antoniewicz LW; Riggs JW; Plunkett BA; Hollier LM
    Am J Perinatol; 2013 Oct; 30(9):759-64. PubMed ID: 23322389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME; Rijnders ME; Dommelen P; Fekkes M; Wouwe JP; Amelink-Verburg MP; Verkerk PH
    BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria.
    Onakewhor JU; Chiwuzie J
    Niger J Clin Pract; 2011; 14(2):140-5. PubMed ID: 21860127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis.
    Prabhu M; Susich MK; Packer CH; Hersch AR; Riley LE; Caughey AB
    Obstet Gynecol; 2022 Mar; 139(3):357-367. PubMed ID: 35115449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of prenatal screening for postpartum thyroiditis.
    Bonds DE; Freedberg KA
    J Womens Health Gend Based Med; 2001 Sep; 10(7):649-58. PubMed ID: 11571094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome.
    Lugnér AK; Mollema L; Ruijs WL; Hahné SJ
    Epidemiol Infect; 2010 Aug; 138(8):1172-84. PubMed ID: 20018128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rubella antibody determination in pregnancy--effectiveness of a screening program].
    Robra BP; Müller HE; Fingscheidt E
    Offentl Gesundheitswes; 1981 Nov; 43(11):559-63. PubMed ID: 6212800
    [No Abstract]   [Full Text] [Related]  

  • 13. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism.
    Thung SF; Funai EF; Grobman WA
    Am J Obstet Gynecol; 2009 Mar; 200(3):267.e1-7. PubMed ID: 19114278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical practices for prevention of perinatal infections in Puerto Rico.
    Dayan GH; Caquías CR; García Y; Malik T; Copeland J; Bi D; Reef S
    Paediatr Perinat Epidemiol; 2008 Jan; 22(1):31-9. PubMed ID: 18173782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women.
    Dosiou C; Barnes J; Schwartz A; Negro R; Crapo L; Stagnaro-Green A
    J Clin Endocrinol Metab; 2012 May; 97(5):1536-46. PubMed ID: 22399510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children with suspected craniosynostosis: a cost-effectiveness analysis of diagnostic strategies.
    Medina LS; Richardson RR; Crone K
    AJR Am J Roentgenol; 2002 Jul; 179(1):215-21. PubMed ID: 12076939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand.
    Boonruang S; Buppasiri P
    J Med Assoc Thai; 2005 Apr; 88(4):455-9. PubMed ID: 16146247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of monitoring pregnant patients exposed to rubella].
    Buchar F; Vieweg C
    Zentralbl Gynakol; 1989; 111(10):645-50. PubMed ID: 2750357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
    Day FL; Karnon J; Rischin D
    J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.